{"name": "AltheRx Pharmaceuticals",
 "permalink": "altherx-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/altherx-pharmaceuticals",
 "homepage_url": "http://altherx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2010,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Fri May 03 04:35:35 UTC 2013",
 "updated_at": "Fri May 03 04:35:35 UTC 2013",
 "overview": "\u003Cp\u003EAltheRx Pharmaceuticals is a privately held, clinical development company focused on advancing best-in-class compounds with high promise in large unmet markets. The Company is focused on clinical development and optimizing commercialization through partnerships. The AltheRx name is a derivative of the name of the Greek goddess of healing, Althea.\u003C/p\u003E\n\n\u003Cp\u003EThe Company\u2019s lead product, Solabegron, is a highly differentiated novel compound being investigated for OAB and IBS, conditions that affect the quality of life for more than 90 million Americans \u2212 a number that will grow significantly as the population ages. Solabegron was discovered and first developed by GlaxoSmithKline and acquired by AltheRx in March 2011.\u003C/p\u003E\n\n\u003Cp\u003EThe company\u2019s co-founders have decades of leadership experience in the pharmaceutical and biotechnology industries.\u003C/p\u003E\n\n\u003Cp\u003EAltheRx was formed in 2010. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[120,
       47],
      "assets/images/resized/0025/7947/257947v1-max-150x150.png"],
     [[120,
       47],
      "assets/images/resized/0025/7947/257947v1-max-250x250.png"],
     [[120,
       47],
      "assets/images/resized/0025/7947/257947v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-founder, Vice-President of Operations",
    "person":
     {"first_name": "Raymond",
      "last_name": "E. Stevens",
      "permalink": "raymond-e-stevens",
      "image": null}},
   {"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jim",
      "last_name": "Bennethum",
      "permalink": "jim-bennethum",
      "image": null}},
   {"is_past": false,
    "title": "Co-founder, CSO, Head of R\u0026D",
    "person":
     {"first_name": "Eliot",
      "last_name": "H. Ohlstein",
      "permalink": "eliot-h-ohlstein",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$15M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2013/05/altherx-pharmaceuticals-receives-15m-financing-becker-ventures.html",
    "source_description": "AltheRx Pharmaceuticals Receives $15M financing from Becker Ventures",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Becker Ventures",
         "permalink": "becker-ventures",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "Exton",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}